Phapros Tbk. vs Tripar Multivision Plus Tbk. — how do they compare? Phapros Tbk. trades at Rp254 (market cap 220.08B, 204.7K 24h volume), while Tripar Multivision Plus Tbk. trades at Rp202 (market cap 1.38T, 1.56M 24h volume). The key difference: Tripar Multivision Plus Tbk. is far larger — about 6.3× Phapros Tbk.'s market cap, and Tripar Multivision Plus Tbk. is more actively traded (1.56M versus 204.7K). Which is the better fit depends on your goals.
| PEHA | RAAM | |
|---|---|---|
Market Cap | 220.08B | 1.38T |
Volume | 204.7K | 1.56M |
Lot | 2.05K | 15.58K |
Turnover | 52.61M | 314.38M |
Average Price | 256.99 | 201.83 |
Value | 52.61M | 314.38M |
Indicative Equilibrium Price | — | 202 |
Indicative Equilibrium Volume | — | 16 |
Trailing returns across standard periods
Latest headlines on both assets
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →